11 completed, 1 terminated. 12 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 12 | Completed 11, Terminated 1 |
Follow fesoterodine: new trials by email Literature Review of fesoterodine trials Research Report on fesoterodine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Estimate the Relative Bioavailability Compared to Commercial Extended-release Tablet Formulation and the Effects of Food Or Sprinkling on Applesauce for Fesoterodine Sustained-release Beads-in-capsule Formulations in Healthy Adult Volunteers Fesoterodine ER (fasted), Fesoterodine SR3 (fasted), Fesoterodine SR3 (fed) - Healthy | Phase 1 | Completed | Pfizer | 24 | 2014-07-01 | 2015-01-15 |
| A Study To Estimate The Effects Of Food On Drug Fesoterodine Fumarate And The Pharmacokinetics Of 5-Hydroxymethyl Tolterodine (5-HMT) In Healthy Volunteers fesoterodine fumarate - Urinary Bladder, Overactive | Phase 1 | Completed | Pfizer | 24 | 2012-05-01 | 2016-08-19 |
| Validation of Instruments for Pragmatic Clinical Trials for Overactive Bladder Toviaz - Overactive Bladder | Phase 1 | Completed | University of Pennsylvania | 75 | 2011-05-01 | 2014-12-10 |
| This Is A Study Of Bioavailability And Food Effect For Fesoterodine. fesoterodine - Overactive Bladder (OAB) With Symptoms of Frequency, Urgency, and Urgency | Phase 1 | Completed | Pfizer | 20 | 2010-12-01 | 2012-01-26 |
| A Study to Assess the Cognitive Effects of Fesoterodine in Elderly Subjects 4mg fesoterodine, 8mg fesoterodine, alprazolam 1mg - Healthy | Phase 1 | Completed | Pfizer | 20 | 2010-07-01 | 2012-06-28 |
| The Effect Of Fesoterodine On Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy Subjects warfarin, Warfarin plus Fesoterodine - Urinary Bladder, Overactive | Phase 1 | Completed | Pfizer | 14 | 2009-07-01 | 2011-06-01 |
| A Bioequivalence Study Of 8 Mg Fesoterodine Extended-Release Tablets (Toviaz™) In Healthy Subjects Fesoterodine - Treatment of Overactive Bladder | Phase 1 | Completed | Pfizer | 36 | 2009-06-01 | 2018-09-28 |
| A Bioequivalence Study Of 4 Mg Fesoterodine Extended-Release Tablets (Toviaz™) In Healthy Subjects Fesoterodine - Treatment of Overactive Bladder | Phase 1 | Completed | Pfizer | 36 | 2009-05-01 | 2018-10-16 |
| The Effect Of Fluconazole On Pharmacokinetics Of Fesoterodine In Healthy Subjects Fesoterodine, fesoterodine plus fluconazole - Overactive Bladder With Symptoms of Frequency, Urgency, and Urge Urinary Incontinence | Phase 1 | Completed | Pfizer | 28 | 2009-05-01 | 2011-06-01 |
| Multiple Dose Study To Investigate The Effects Of Fesoterodine And Solifenacin On Gastrointestinal Transit fesoterodine fumarate, placebo, solifenacin - Healthy | Phase 1 | Terminated | Pfizer | 60 | 2009-04-01 | 2010-12-24 |
| Phase1, Single Dose, Crossover Study to Determine Bioequivalence Fesoterodine - Healthy | Phase 1 | Completed | Pfizer | 37 | 2009-01-01 | 2010-09-09 |
| Phase 1, Single Dose, Crossover Study to Determine Bioequivalence and to Investigate Food Effect Fesoterodine - Therapeutic Equivalency, Food | Phase 1 | Completed | Pfizer | 108 | 2008-10-01 | 2010-03-24 |
Urinary Bladder, Overactive (4) · Urinary Incontinence, Urge (2)
Pfizer (11) · University of Pennsylvania (1)
United States (8) · Singapore (2) · Belgium (1) · Japan (1)
2014 (1)